Literature DB >> 7226706

Cimetidine plasma concentration-response relationships.

R Gugler, G Fuchs, M Dieckmann, A A Somogyi.   

Abstract

Cimetidine plasma concentration-response relationships were investigated in six healthy subjects using suppression of gastric acid secretion under continuous pentagastrin stimulation (1.5 micrograms/kg/hr) as a test model. With the Hill equation the sigmoid was preferable to the linear relationship between plasma concentration and effect, and there were significant correlations of 0.78 micrograms/ml (range 0.54 to 1.04 micrograms/ml) for 50% inhibition of gastric acid secretion was determined; mean concentration for 90% inhibition was calculated to be 3.9 micrograms/ml. The model described should allow determination of whether different patient populations (e.g., healthy subjects, patients with ulcers, male and female patients, patients with renal or liver disease) differ from one another in concentration-response relationships to histamine H2-receptor antagonists, so that appropriate drug plasma levels should be achieved for specific degrees of inhibition of gastric acid secretion.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7226706     DOI: 10.1038/clpt.1981.105

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  21 in total

Review 1.  Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.

Authors:  J H Lin
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

2.  Modulation of gastric pH by continuous gastric and jejunal infusion of cimetidine.

Authors:  U K Murthy; W G Linscheer
Journal:  Dig Dis Sci       Date:  1991-02       Impact factor: 3.199

Review 3.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

4.  Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth.

Authors:  Steve N Caritis; Raman Venkataramanan; Elizabeth Thom; Margaret Harper; Mark A Klebanoff; Yoram Sorokin; John M Thorp; Michael W Varner; Ronald J Wapner; Jay D Iams; Marshall W Carpenter; William A Grobman; Brian M Mercer; Anthony Sciscione; Dwight J Rouse; Susan Ramin
Journal:  Am J Obstet Gynecol       Date:  2013-10-07       Impact factor: 8.661

5.  Pharmacokinetics of mifentidine after single and multiple oral administration to healthy volunteers.

Authors:  B P Imbimbo; R Urso; G Thieme; B Sturn; B Ueckert; A Vidi; H Ladinsky; S Daniotti
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

6.  The influence of duration of intravenous infusion of an acute dose on plasma concentrations of cimetidine.

Authors:  D J Morgan; D A Uccellini; K Raymond; G W Mihaly; D B Jones; R A Smallwood
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Refractory duodenal ulcer.

Authors:  K D Bardhan
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

8.  Ranitidine upon meal-induced gastric secretion: oral pharmacokinetics and plasma concentration effect relationships.

Authors:  M Mignon; N P Chau; B K Nguyen-Phuoc; M Sauvage; F Leguy; S Bonfils
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

Review 9.  Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

Review 10.  Clinical pharmacokinetics of cimetidine.

Authors:  A Somogyi; R Gugler
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.